HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir

by Harel Dahari, Laetitia Canini, Frederik Graw, Susan L. Uprichard, EvaldoS A. Araujo, Guillaume Penaranda, Emilie Coquet, Aurélie Riso, Christophe Renou, Marc Bourlière, Scott J. Cotler, Philippe Halfon
Published 2016-05-01